Drug Trial Radar · NCT04880512
The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects
Last checked: Nov 20, 2026Latest source record: Sep 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
102
Planned (sponsor's estimate)
Start
May 31, 2021
Primary completion
Aug 20, 2022
Study completion Dec 20, 2022
Sponsor
- Lead sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 10, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a phase I clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of single ascending doses and multiple ascending doses of SYHX1901 tablets in Chinese healthy subjects
Conditions
- Healthy Subjects
Interventions
SYHX 1901 tabletsDrug
SYHX 1901, oral tablets, in fasted state
PlaceboDrug
Matching placebo, oral tablets, in fasted state
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability of SYHX1901 tabletsTime frame: SAD: up to14 days after the dosing, MAD: up to 7 days after the last dosing
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Huashan Hospital of Fudan University
Shanghai, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.